Aegerion Pharmaceuticals files for $86.25 mln IPO
WASHINGTON, March 21 (Reuters) - Aegerion Pharmaceuticals Inc. filed with regulators on Wednesday to raise up to $86.25 million in an initial public offering of common stock.
The Bridgewater, New Jersey-based biopharmaceutical company said in a preliminary filing with the U.S. Securities and Exchange Commission that Lehman Brothers, CIBC World Markets, Thomas Weisel Partners and C.E. Unterberg Towbin were underwriting the IPO.
Aegerion did not reveal the terms of the offering in the filing, but said it had applied to list its stock on Nasdaq under the symbol "AEGR." (AEGR.O)
((Reporting by Karey Wutkowski, Reuters Messaging: karey.wutkowski.reuters.com@reuters.net; E-mail:karey.wutkowski@reuters.com +1 202 898 8399)) Keywords: AEGERION IPO/
(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nN21260729
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters